title: Bilateral subdural hemorrhage as a serious adverse event of dasatinib in a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia.
authors.forename: Ho-Young
authors.initials: HY
authors.lastname: Yhim
authors.forename: Hee Sun
authors.initials: HS
authors.lastname: Kim
authors.forename: Na-Ri
authors.initials: NR
authors.lastname: Lee
authors.forename: Eun-Kee
authors.initials: EK
authors.lastname: Song
authors.forename: Jae-Yong
authors.initials: JY
authors.lastname: Kwak
authors.forename: Chang-Yeol
authors.initials: CY
authors.lastname: Yim
mesh_terms: D000069439:Dasatinib; D005260:Female; D006470:Hemorrhage / Q000139:chemically induced* / Q000473:pathology; D006801:Humans; D008875:Middle Aged; D010677:Philadelphia Chromosome; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000150:complications / Q000188:drug therapy*; D047428:Protein Kinase Inhibitors / Q000009:adverse effects*; D011743:Pyrimidines / Q000009:adverse effects*; D013355:Subdural Space / Q000187:drug effects / Q000473:pathology; D013844:Thiazoles / Q000009:adverse effects*; D013921:Thrombocytopenia / Q000150:complications
chemical_list: D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D013844:Thiazoles; D000069439:Dasatinib